| J9271 | Injection, pembrolizumab, 1 mg | 14,400 | $40 | $619.2K |
| J0897 | Injection, denosumab, 1 mg | 6,720 | $20 | $121K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,340 | $40 | $84.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 450 | $100 | $44.8K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 6,740 | $10 | $40.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 390 | $100 | $40.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 270 | $140 | $37.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 290 | $70 | $20K |
| J0185 | Injection, aprepitant, 1 mg | 13,780 | $1 | $13.8K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 80 | $170 | $13.7K |